Our study found that ADAM17 inhibition combined with eplerenone significantly improved myocardial fibrosis, apoptosis, and inflammation in diabetic mice by dual inhibition of Ang II and aldosterone, without affecting blood potassium concentration. Here, AGT is linked to Myocardial fibrosis.